Shree Shyam Globals

Tacrolimus hard capsules are an immunosuppressant primarily used to prevent organ rejection in transplant patients. They work by weakening the body's immune system so it does not attack the new organ. 
Common alternatives in India

• Pangraf (by Mankind Pharma Ltd.)
• Tacromus (by Zydus Cadila)
• Tacrograf (by Eris Lifesciences Ltd.)
• Takfa (by Intas Pharmaceuticals Ltd.)
• Vingraf (by Emcure Pharmaceuticals Ltd.)
• Tacrosan (by J B Chemicals and Pharmaceuticals)
• Tacroren (by La Renon Healthcare Pvt Ltd)
• Tacsant (by Novartis India Ltd.) 

Tacrocord 1mg capsules contain the immunosuppressant medication tacrolimus, which is primarily used to prevent organ rejection in patients who have received a transplant

Commonly available alternatives  include:

• Pangraf 1 Capsule 
• Tacrograf 1 Capsule 
• Tacroren 1 Capsule
• Vingraf 1 Capsule 
• Takfa 1 Capsule 
• Prograf 1 mg Capsule
• Biomus-1 Capsule 
• Grafnos 1Mg Capsule 
• Tacsant 1 mg Capsule
• Rolitrans 1mg Capsule 

Takfa 0.5 mg capsules, which contain the active ingredient tacrolimus, are primarily used to prevent the body from rejecting a new organ (e.g., liver, kidney, heart, or lung) after a transplant. 

Available alternatives to 0.5mg Takfa Tacrolimus capsules include-:

Pangraf, Tacromus, Tacrograf, Vingraf, and Tacroren. These medicines contain the same active ingredient, tacrolimus (0.5mg), and are used to prevent organ rejection after a transplant.